“renaissance-capital” Archives

in
Entry Author Date Location
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials 04/03/20 New York
Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO 03/12/20 Boston
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street 10/03/19 National
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
Lyft Raises $2.2B in IPO, Pegging Valuation at Over $24B 03/28/19 San Francisco
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology 10/31/18 San Francisco
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly 09/20/18 Indiana
Principia Sets IPO Terms as It Eyes Late-Stage Studies for Lead Drug 09/04/18 San Francisco
Eventbrite Targets $200M IPO as Tech, Biotech Markets Remain Hot 08/23/18 San Francisco
Entasis Therapeutics and Principia Biopharma Join the IPO Queue 08/20/18 Boston
Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals 08/03/18 Indiana
Rubius Upsizes IPO and Hauls in $241M for Red Blood Cell Therapies 07/18/18 Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Carbon Black Raising $152M as Tech IPOs Stage Comeback 05/03/18 Boston
Surface Oncology’s Upsized IPO Reels In $108M for Lead Cancer Drug 04/18/18 Boston
SailPoint & WatchGuard IPO, HX, Technium, ResMan, & More Texas News 11/01/17 Texas
Page 1 of 3 next page »